Company Response to NSE Volume Query

SMS Pharmaceuticals Limited has formally responded to a clarification sought by the National Stock Exchange of India Ltd. regarding a significant increase in the trading volume of its equity shares.

Date and Nature of Exchange Query

  • Date of Communication: 1st July 2026 (Response Date)
  • Query Date: 30th June 2026
  • Nature of Query: The National Stock Exchange's Surveillance Department sought clarification from the company regarding a spurt in the volume of its equity shares, referenced under news sequence no. 17190 dated 30th June 2026.

Company's Clarification on Trading Volume

  • The company stated that it has been "duly complying and diligently disclosing all the material events, information, that have a bearing on the operations/performance of the Company."
  • SMS Pharmaceuticals confirmed it has not withheld any material information, announcement, or event that would have a bearing on the price/volume behavior of its shares.
  • The company attributed the volume spurt to "purely market conditions and absolutely market driven" factors, indicating no company-specific undisclosed development caused the trading activity.

Regulatory Compliance Reference

  • The company specifically referenced its compliance with "Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015."
  • It emphasized that all price sensitive information has been disclosed in accordance with these regulations from time to time.

Financial Results Clarification

  • The document does not contain any specific discussion or clarification regarding financial results. The response focuses exclusively on the trading volume inquiry.

Signature and Authorization

  • The response was digitally signed by Thirumalesh Tumma, Company Secretary of SMS Pharmaceuticals Limited, on 1st July 2026 at 14:43:26 IST.
  • The communication was addressed to the Manager, Surveillance Department, National Stock Exchange of India Ltd. at Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Topic Tags: Regulatory Response, Stock Trading, Volume Increase, Compliance, SEBI Regulation 30